MAP2K7 and glioblastoma: Phosphorylated-MEK (Ser221) and -ERK (Thr202/Tyr204) were both decreased in valtrate-treated cells, while phosphorylated-PI3K (Tyr458) and -AKT (Thr308) remained unchanged in all three GBM cell lines (Fig. 5C).